|
| Exchange Received Time 01/05/2018 12:10:05 Exchange Disseminated Time 01/05/2018 12:10:09 Time Taken 00:00:04 | This is in continuation to our letter Ref. No. FHL/SEC/STEX/RR/2018-19 dated April 23, 2018 whereby, it was informed that the Board of Directors of Fortis Healthcare Limited ('the Company') has received a letter, extending the validity period of Improved Offer till May 4, 2018, and all other terms and conditions of the Improved Offer remain unchanged, from Munjal's Office and Burman's Office with a proposal to invest in the Company.
It is hereby informed that the Company today i.e. May 1, 2018, has received modified Investment Proposal, as attached herewith, from Munjal's Office and Burman's Office to invest directly into the Company.
We will keep the stock exchanges updated/informed in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
This is for your information and records please. We assure you of our full cooperation at all times.
|
|
|